AmerisourceBergen Corporation - COR Net Assets per Single Share

Cencora, Inc. (COR) faces margin pressure and litigation, with the indicator level standing at 15.92. A key book value metric demonstrates an equilibrium between profits and costs. An efficient cold chain optimizes drug delivery, while the company's oligopolistic status and operational scale create a powerful defensive moat, ensuring resilience within the distribution market.

Accounting Value of a Share: Cencora Inc (COR) for 02/21/2024 - 10/27/2026

cencora.com - analytical breakdowns and key metrics (COR)

- price and consensus price forecast:

Price Chart AmerisourceBergen|COR - Fair Value Consensus

- market capitalization data:

Market Value Cencora, Inc.|COR - Full Business Value

- book capitalization data:

Book Value per Share Cencora|COR - Accounting Value of Company|Market Capitalization to Book Value Ratio cencora.com|COR - Company Total Assets

- debt and liquidity data:

Debt to Equity Cencora, Inc.|COR - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Cencora|COR - Company Total Debt|Debts to Book Capitalization Cencora, Inc.

Analysis of all company metrics:AmerisourceBergen (COR)

Cencora, Inc. (COR) is strengthening its position in pharmaceutical distribution through strategic alliances and M&A expansion. This metric determines the net asset value per share after deducting all liabilities. By analyzing the book value per share, an investor assesses the real asset protection of the capital. The positive trend on this chart confirms the growth of the business's material backing. A steady increase in this value guarantees the company's resilience during market turmoil.

Competitors of Cencora, Inc. (COR)